Prevalence of a metabolic syndrome phenotype in adolescents: Findings from the Third National Health and Nutrition Examination Survey, 1988-1994

Archives of Pediatrics and Adolescent Medicine

Volumn 157, Issue 8, 2003, Pages 821-827

  Cook, Stephen ^a   Weitzman, Michael ^a,b   Auinger, Peggy ^a   Nguyen, Michael ^a,b   Dietz, William H ^c  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b Amer Acad Pediat Ctr Child H   (United States)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEX RATIO; UNITED STATES;

ADOLESCENT; ADULT; BODY MASS INDEX; CHILD; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; FEMALE; HEALTH SURVEYS; HUMANS; MALE; METABOLIC SYNDROME X; PHENOTYPE; PREVALENCE; SEX DISTRIBUTION; UNITED STATES;

EID: 0043240339     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.157.8.821     Document Type: Article

References (65)

1. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195-1200.
2. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288:1723-1727.
3. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC Growth Charts for the United States: Methods and Development. Hyattsville, Md: National Center for Health Statistics; 2002. Vital and Health Statistics Series 11, No. 246. DHHS Publication PHS 2002-1696.
4. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA. 2002;288:1728-1732.
5. US Department of Health and Human Services. The Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity 2001. Rockville, Md: Public Health Service, Office of the Surgeon General; 2001.
6. Pearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases; American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002;106:388-391.
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
8. National Cholesterol Education Program. Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Full Report. Bethesda, Md: National Institutes of Health; 2001. NIH publication No. 01-3670.
9. Ford ESG. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359.
10. Troiano RP, Flegal KM, Kuczmarski RJ, Campbell SM, Johnson CL. Overweight prevalence and trends for children and adolescents: the National Health and Nutrition Examination Surveys, 1963 to 1991. Arch Pediatr Adolesc Med. 1995;149:1085-1091.
11. Troiano RP, Flegal KM. Overweight children and adolescents: description, epidemiology, and demographics. Pediatrics. 1998;101 (suppl 3):497-504.
12. Dietz WH. Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics. 1998;101(suppl 3):518-525.
13. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr. 1996;128(5 pt 1):608-615.
14. Styne DM. Childhood and adolescent obesity: prevalence and significance. Pediatr Clin North Am. 2001;48:823-854.
15. Falkner B, Hassink S, Ross J, Gidding S. Dysmetabolic syndrome: multiple risk factors for premature adult disease in an adolescent girl. Pediatrics. 2002;110(1 pt 1):e14. Available at: http://www.pediatrics.org/cgi/content/f ull/110/1/e14. Accessed August 5, 2002.
16. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics. 1999;103(6 pt 1):1175-1182.
17. McGill HC Jr, McMahan CA, Herderick EE, et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation. 2002;105:2712-2718.
18. US Department of Health and Human Services. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-94. Hyattsville, Md: National Center for Health Statistics; 1994. Vital and Health Statistics Series 1, No. 32. DHHS Publication PHS 94-1308.
19. Fagot-Campagna A, Saaddine JB, Flegal KM, Beckles GL. Diabetes, impaired fasting glucose, and elevated HbA1c in US adolescents: the Third National Health and Nutrition Examination Survey. Diabetes Care. 2001;24:834-837.
20. Sun SS, Schubert CM, Chumlea WC, et al. National estimates of the timing of sexual maturation and racial differences among US children. Pediatrics. 2002;110:911-919.
21. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics. 1996;98(4 pt 1):649-658.
22. National Cholesterol Education Panel. Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Bethesda, Md: National Institutes of Health; 1991. NIH Publication No. 91-2732.
23. Type 2 diabetes in children and adolescents. Diabetes Care. 2000;23:381-389.
24. SAS, Version 8.2 [computer program]. Cary, NC: SAS Institute Inc; 1999.
25. Shah BV, Barnwell BG, Bieler GS. SUDAAN User's Manual, Release 7.5. Research Triangle Park, NC: Research Triangle Institute; 1997.
26. Hjermann I. The metabolic cardiovascular syndrome: syndrome X, Reaven's syndrome, insulin resistance syndrome, atherothrombogenic syndrome. J Cardiovasc Pharmacol. 1992;20(suppl 8):S5-S10.
27. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-553.
28. Grundy SM. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation. 2002;105:2696-2698.
29. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA. 1990;263:2893-2898.
30. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes. 1992;41:715-722.
31. lsomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-689.
32. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163:427-436.
33. Chen W, Srinivasan SR, Elkasabany A, Berenson GS. Cardiovascular risk factors clustering features of insulin resistance syndrome (syndrome X) in a biracial (black-white) population of children, adolescents, and young adults: the Bogalusa Heart Study. Am J Epidemiol. 1999;150:667-674.
34. Csabi G, Torok K, Jeges S, Molnar D. Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr. 2000;159:91-94.
35. Dwyer T, Blizzard L, Venn A, Stankovich JM, Ponsonby AL, Morley R. Syndrome X in 8-y-old Australian children: stronger associations with current body fatness than with infant size or growth. Int J Obes Relat Metab Disord. 2002;26:1301-1309.
36. Maffeis C, Pietrobelli A, Grezzani A, Provera S, Tato L. Waist circumference and cardiovascular risk factors in prepubertal children. Obes Res. 2001;9:179-187.
37. Guo SS, Roche AF, Chumlea WC, Gardner JD, Siervogel RM. The predictive value of childhood body mass index values for overweight at age 35 y. Am J Clin Nutr. 1994;59:810-819.
38. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med. 1997;337:869-873.
39. Vanhala M, Vanhala P, Kumpusalo E, Halonen P, Takala J. Relation between obesity from childhood to adulthood and the metabolic syndrome: population based study. BMJ. 1998;317:319-320.
40. Bao W, Srinivasan SR, Berenson GS. Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults: the Bogalusa Heart Study. Circulation. 1996;93:54-59.
41. Dobbelsteyn CJ, Joffres MR, MacLean DR, Flowerdew G. A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors: the Canadian Heart Health Surveys. Int J Obes Relat Metab Disord. 2001;25:652-661.
42. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med. 2002;162:2074-2079.
43. Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr. 2002;75:683-688.
44. Thompson CJ, Ryu JE, Craven TE, Kahl FR, Crouse JR. Central adipose distribution is related to coronary atherosclerosis. Arterioscler Thromb. 1991;11:327-333.
45. Van Pelt RE, Evans EM, Schechtman KB, Ehsani AA, Kohrt WM. Waist circumference vs body mass index for prediction of disease risk in postmenopausal women. Int J Obes Relat Metab Disord. 2001;25:1183-1188.
46. Freedman DS, Serdula MK, Srinivasan SR, Berenson GS. Relation of circumferences and skinfold thickness to lipid and insulin concentrations in children and adolescents: the Bogalusa Heart Study. Am J Clin Nutr. 1999;69:308-317.
47. Savva SC, Tornaritis M, Savva ME, et al. Waist circumference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index. Int J Obes Relat Metab Disord. 2000;24:1453-1458.
48. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev. 1994;74:761-811.
49. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement. Circulation. 2003;107:1448-1453.
50. Daniels SR, Khoury PR, Morrison JA. Utility of different measures of body fat distribution in children and adolescents. Am J Epidemiol. 2000;152:1179-1184.
51. Reilly JJ, Dorosty AR, Emmett PM. Identification of the obesechild: adequacy of the body mass index for clinical practice and epidemiology. Int J Obes Relat Metab Disord. 2000;24:1623-1627.
52. Kavey RE, Daniels SR, Lauer RM, et al. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation. 2003;107:1562-1566.
53. Williams CL, Hayman LL, Daniels SR, et al. Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2002;106:143-160.
54. Guo S, Beckett L, Chumlea WC, Roche AF, Siervogel RM. Serial analysis of plasma lipids and lipoproteins from individuals 9-21 y of age. Am J Clin Nutr. 1993;58:61-67.
55. Raitakari OT, Porkka KV, Rasanen L, Ronnemaa T, Viikari JS. Clustering and 6 year cluster-tracking of serum total cholesterol, HDL-cholesterol and diastolic blood pressure in children and young adults: the Cardiovascular Risk in Young Finn Study. J Clin Epidemiol. 1994;47:1085-1093.
56. Barlow SE, Dietz WH. Obesity evaluation and treatment: Expert Committee recommendations. Pediatrics. 1998;102::e29. Available at: http://www.pediatrics .org/cgi/content/full/102/3/e29. Accessed August 5, 2002.
57. Himes JH, Dietz WH. Guidelines for overweight in adolescent preventive services: recommendations from an expert committee: the Expert Committee on Clinical Guidelines for Overweight in Adolescent Preventive Services. Am J Clin Nutr. 1994;59:307-316.
58. American Academy of Pediatrics. National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 1992;89(3 pt 2):525-584.
59. American Academy of Pediatrics Committee on Nutrition. Cholesterol in childhood. Pediatrics. 1998;101(1 pt 1):141-147.
60. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA. 2002;288:1728-1732.
61. Freedman DS, Bowman BA, Otvos JD, Srinivasan SR, Berenson GS. Differences in the relation of obesity to serum triacylglycerol and VLDL subclass concentrations between black and white children: the Bogalusa Heart Study. Am J Clin Nutr. 2002;75:827-833.
62. Kimm SY, Obarzanek E. Childhood obesity: a new pandemic of the new millennium. Pediatrics. 2002;110:1003-1007.
63. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
64. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537-544.
65. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350.